Through the 90-day period concluding February 15, 2026, Revelation Biosciences's top three insider stakeholders include Chief Executive Officer James Rolke (224.85K shares), Chief Financial Officer Chester Stanley Iii Zygmont (105.35K shares), Director Jess Roper (12.83K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Capital, Llc Glazer | 0 | 23 Sep, 2021 | |
| James Rolke | Chief Executive Officer | 224,853 | 05 Feb, 2026 |
| Chester Stanley Iii Zygmont | Chief Financial Officer | 105,348 | 05 Feb, 2026 |
| Jess Roper | 12,828 | 05 Feb, 2026 | |
| Jennifer Carver | 12,758 | 05 Feb, 2026 | |
| Lakhmir S Chawla | 12,158 | 05 Feb, 2026 | |
| George F Tidmarsh | 2 | 12 Dec, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 04 Feb, 2026 | Chester Stanley Iii Zygmont | Common Stock | D | 13,100 | $1.65 | 105,348 | I | F |
| 03 Feb, 2026 | Jess Roper | Common Stock | D | 1,591 | $1.85 | 12,828 | D | F |
| 03 Feb, 2026 | Lakhmir S Chawla | Common Stock | D | 2,261 | $1.85 | 12,158 | D | F |
| 03 Feb, 2026 | Jennifer Carver | Common Stock | D | 1,661 | $1.87 | 12,758 | D | F |
| 03 Feb, 2026 | James Rolke | Common Stock | D | 8,521 | $1.86 | 224,853 | D | F |
| 08 Jan, 2026 | Jess Roper | Common Stock | A | 41,981 | $0.90 | 3,922 | D | A |
| 08 Jan, 2026 | Lakhmir S Chawla | Common Stock | A | 41,981 | $0.90 | 3,922 | D | A |
| 08 Jan, 2026 | Jennifer Carver | Common Stock | A | 41,981 | $0.90 | 3,922 | D | A |
| 08 Jan, 2026 | James Rolke | Common Stock | A | 532,829 | $0.90 | 100,165 | D | A |
| 08 Jan, 2026 | Chester Stanley Iii Zygmont | Common Stock | A | 78,145 | $0.90 | 98,910 | I | A |
| 29 Oct, 2025 | Jess Roper | Common Stock | A | 15,625 | $1.28 | 15 | D | A |
| 29 Oct, 2025 | Lakhmir S Chawla | Common Stock | A | 15,625 | $1.28 | 15 | D | A |
| 29 Oct, 2025 | Jennifer Carver | Common Stock | A | 15,625 | $1.28 | 16 | D | A |
| 29 Oct, 2025 | James Rolke | Common Stock | A | 390,614 | $1.28 | 2,512 | D | A |
| 29 Oct, 2025 | Chester Stanley Iii Zygmont | Common Stock | A | 390,614 | $1.28 | 1,257 | I | A |
| 11 Feb, 2025 | George F Tidmarsh | Common Stock | A | 181 | $3.87 | 2 | I | A |
| 11 Feb, 2025 | George F Tidmarsh | - | - | 2 | I | |||
| 11 Feb, 2025 | Jess Roper | Common Stock | A | 181 | $3.87 | 0 | D | A |
| 11 Feb, 2025 | Lakhmir S Chawla | Common Stock | A | 181 | $3.87 | 4 | D | A |
| 11 Feb, 2025 | Jennifer Carver | Common Stock | A | 181 | $3.87 | 0 | D | A |